CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to improve early detection of colorectal cancer by identifying biomarkers in urine. By developing non-invasive testing methods, the goal is to facilitate widespread screening and significantly enhance survival rates through earlier diagnosis.
Colorectal cancer (CRC) is the most common neoplastic pathology in the developed world.
It is the second in frequency in men after prostate cancer and the second in women after breast cancer.
Survival at five years, if all stages are taken into account, is approximately 50%.
That represents a mortality of 20 cases per 100,000 inhabitants per year.
The five-year survival of early stages, a situation almost equivalent to cure, is approximately 90%, whereas in advanced or metastatic stages it is le…
Institut de Recerca Biomedica Catalunya Sud (IRBCatSud)
FUNDACIO INSTITUT D'INVESTIGACIO SANITARIA PERE VIRGILI (IISPV)
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
LOS ANGELES UCLA SANTA BARBARA UCSB DAVIS UCD RIVERSIDE UCR SAN DIEGO UCSD SANTA CRUZ UCSC IRVIN
United States, Berkeley
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
